Phase I Scintigraphy Study of A Radiolabeled Solution of Ciclesonide Hydrofluroalkane Nasal Aerosol And A Radiolabeled Suspension of Ciclesonide Aqueous Nasal Spray in Healthy Subjects.

Trial Profile

Phase I Scintigraphy Study of A Radiolabeled Solution of Ciclesonide Hydrofluroalkane Nasal Aerosol And A Radiolabeled Suspension of Ciclesonide Aqueous Nasal Spray in Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Nov 2012

At a glance

  • Drugs Ciclesonide (Primary)
  • Indications Asthma; Perennial allergic rhinitis; Seasonal allergic rhinitis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 28 Nov 2012 New trial record
    • 12 Nov 2012 Results were presented at the 2012 Annual Meeting of the American College of Allergy, Asthma and Immunology (ACAAI), according to a Sunovion Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top